Welcome. Please log in or create an account.

Call to waive patent and intellectual property protections for COVID-19 tests and therapies

• Univadis Medical News
• 23 November 2020

Countries could choose not to grant or enforce patents and other intellectual property measures until global herd immunity is achieved.

ESMO Guideline for managing myelodysplastic syndromes

• Univadis Medical News
• 23 November 2020

ESMO Clinical Practice Guideline provides key recommendations on diagnosis, classification, staging and risk assessment of myelodysplastic syndromes.

Veganism: vitamin B12 is not affected but iodine is a matter of concern

• Univadis Medical News
• 23 November 2020

In one-third of vegans, iodine excretion was lower than the WHO threshold for severe iodine deficiency.

ESMO 2020 — Swiss study: half of new cancer drugs lack substantial clinical benefit

• Oncology Conference reports
• 01 October 2020

Drug approval without substantial clinical benefit happens more often than not.

ESMO 2020 — Tackling health-related QoL mCRC after first-line immunotherapy

• Oncology Conference reports
• 01 October 2020

Pembrolizumab significantly improves health-related QoL vs standard of care in a patient subgroup.

ESMO 2020 — A new standard first-line therapy for advanced gastric/gastroesophageal junction/esophageal cancers?

• Oncology Conference reports
• 01 October 2020

Nivolumab is the first PD-1 inhibitor to show benefit in this population and could be a new potential standard therapy.